Vorapaxar in the secondary prevention of atherothrombotic events

Autor: Jose Nicolau, Andrzej Rynkiewicz, Keith Fox, Vahid Mansouri, Fausto Miranda Junior, Jose Antônio Marin-Neto, Carlos Tauil, Yves Samson, Giovanni ESPOSITO, David Morrow, Wojciech Sobiczewski, James Spratt, Jacek Kubica, Miguel Urina, STEFANO CARUGO, Majken Karoline Jensen, Frans Van de Werf, Stavros Konstantinides, Oscar Ayo-Martin, Lucia Mazzolai, Isabella TRITTO, ERIC HERNANDEZ-TRIANA, Philip Bath, Diana Gorog, Graeme Hankey, Juhani Airaksinen, Marco Vatrano, Jose Faria Neto, Peter Sinnaeve, Roman Herzig, Serge Timsit, Urszula Fiszer, Attila Csányi, Marcia Chaves, Robert Mikulik, Marek Roik, Mónica Jaramillo, Michel GALINIER, Helle Klingenberg Iversen, Bassem A. Samad, Philippe Gabriel STEG, Elizabeth Coetsee, Guillermo Isasti, Domenico Scrutinio, Silvia Reverté Villarroya, Malcolm Robert Macleod, Michael Lim, Amos Katz, Meyer ELBAZ, Derek Chew, Hanne Christensen, Markus Theurl, Simona Marcheselli, Patricia Simal, Michal Bar, Isabelle Quere, Geert Vanhooren, Piotr Ponikowski, Xavier Garcia-Moll, Elena Corrada, Robert Welsh, Helge Wuttig, Philip Aylward, Carl Magnus Wahlgren, Marco Stramba-Badiale, Fernando Manzur, LAURENT SUISSA, Thierry Moulin, Giancarlo Marenzi, Gian Battista Danzi, Bogumił Ramotowski, Caitrin McDonough, Afanasiev Stanislav, RAUL CARLOS REY, Emilia Solinas

Publikováno v: New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2012, 366 (15), pp.1404-13. ⟨10.1056/NEJMoa1200933⟩
The New England Journal of Medicine, 366, 15, pp. 1404-13
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
The New England Journal of Medicine, 366, 1404-13
NEW ENGLAND JOURNAL OF MEDICINE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Morrow, D A, Braunwald, E, Bonaca, M P, Ameriso, S F, Dalby, A J, Fish, M P, Fox, K A A, Lipka, L J, Liu, X, Nicolau, J C, Ophuis, A J O, Paolasso, E, Scirica, B M, Spinar, J, Theroux, P, Wiviott, S D, Strony, J, Murphy, S A, TRA 2P–TIMI 50 Steering Committee and Investigators & Rasmussen, L H 2012, ' Vorapaxar in the secondary prevention of atherothrombotic events ', The New England Journal of Medicine, vol. 366, no. 15, pp. 1404-13 . https://doi.org/10.1056/NEJMoa1200933
New England Journal of Medicine, 2012, 366 (15), pp.1404-13. ⟨10.1056/NEJMoa1200933⟩
The New England journal of medicine, Vol. 366, no. 15, p. 1404-13 (2012)

BACKGROUND: Thrombin potently activates platelets through the protease-activated receptor PAR-1. Vorapaxar is a novel antiplatelet agent that selectively inhibits the cellular actions of thrombin through antagonism of PAR-1. METHODS: We randomly assi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7aa53d65bb0e658f5b67197309da2c89
http://hdl.handle.net/10447/94482

Uso do ultrassom intracoronariano para a caracterização da doença arterial coronariana em pacientes com doença renal crônica

Autor: Varela, A. M., Taniguchi, E., Stadler, N., Jose Faria Neto, Pecoits-Filho, R.

Publikováno v: Scopus-Elsevier
Brazilian Journal of Nephrology, Vol 33, Iss 4, Pp 413-421 (2011)
Brazilian Journal of Nephrology v.33 n.4 2011
Jornal Brasileiro de Nefrologia
Sociedade Brasileira de Nefrologia (SBN)
instacron:SBN
Jornal Brasileiro de Nefrologia, Volume: 33, Issue: 4, Pages: 413-421, Published: DEC 2011

INTRODUCTION: Chronic kidney disease patients present a very high cardiovascular mortality. Nevertheless, a comparative description of lesion characteristics, using intravascular ultrasound in dialysis patients, has not yet been reported. The objecti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9acbd14b5f487799497d3b77e5e8c744
http://www.scopus.com/inward/record.url?eid=2-s2.0-84866286870&partnerID=MN8TOARS